Novel compound as ron inhibitor

A compound represented by Chemical Formula 1 below, or a pharmaceutically acceptable salt thereof:

• in Chemical Formula 1,
• X is N or C;
• R1 is any one selected from the group consisting of hydrogen, a halogen, a substituted or unsubstituted alkyl, and a substituted or unsubstituted cycloalkyl;
• R2 is any one selected from the group consisting of hydrogen and a substituted or unsubstituted alkyl;
• Y1 and Y2 are each independently any one selected from the group consisting of hydrogen, a halogen, a substituted or unsubstituted alkyl, and a substituted or unsubstituted cycloalkyl;
• Z is any one selected from the group consisting of hydrogen, a halogen, a substituted or unsubstituted alkyl, a substituted or unsubstituted alkenyl, a substituted or unsubstituted alkynyl, a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted heterocycloalkyl, a substituted or unsubstituted aryl, a substituted or unsubstituted heteroaryl, a nitro, a cyano, and —(CH2)n—W, wherein n is an integer from 0 to 3, W is —NRaRb, —ORa or a heterocycloalkyl, wherein Ra and Rb are each independently hydrogen or a substituted or unsubstituted alkyl;
• A is any one selected from the group consisting of hydrogen, a substituted or unsubstituted alkyl, a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted heterocycloalkyl, a substituted or unsubstituted aryl, and a substituted and unsubstituted heteroaryl;
• and
• the substituted functional groups are groups substituted with at least one selected from the group consisting of a halogen, an alkyl, a hydroxyalkyl, a hydroxy, an alkoxy, an haloalkyl, an alkoxyalkyl, —(CO)—(CH2)n—ORc, and an aryl, wherein n is an integer from 0 to 3, and Rc is hydrogen or an alkyl.